CLGN

CollPlant Biotechnologies Ltd. operates in the orthopedic, prosthetic & surgical appliances & supplies industry. listed on NASDAQ. headquartered in REHOVOT, L3.

CollPlant Biotechnologies Ltd (CLGN) is publicly traded on NASDAQ within the Healthcare sector , specifically in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry. The company is headquartered in REHOVOT, L3.

Business classification: According to SEC filings, CollPlant Biotechnologies Ltd falls under SIC code 3842 — Orthopedic, Prosthetic & Surgical Appliances & Supplies. This classification helps investors compare the company against peers in similar regulatory and operational environments.

Sector outlook: Companies in the Healthcare sector typically share exposure to similar macroeconomic factors — interest rates, regulatory shifts, and consumer demand patterns specific to this industry vertical. Investors evaluating CLGN should benchmark against other Healthcare stocks for comparative analysis.

Industry-specific factors: The Orthopedic, Prosthetic & Surgical Appliances & Supplies industry has specific competitive dynamics — market share concentration, supply chain dependencies, and capital intensity that affect valuation. Compare CLGN with peer companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies to assess relative positioning.

Regulatory disclosures: With CIK 0001631487, CollPlant Biotechnologies Ltd files mandatory disclosures with the U.S. Securities and Exchange Commission. These include 10-K annual reports, 10-Q quarterly reports, and 8-K material event filings — accessible via the official SEC EDGAR portal for fundamental research.

This page is for educational and research purposes only and does not constitute investment advice. Always conduct independent due diligence and consult a licensed financial advisor before making investment decisions.